Independent information. England-wide.Public data. Clear sources.

NCT06525220

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

Registered research study with 10 identifiable England locations. See source dates, location-specific recruitment and the original study record.

Study facts

Conditions recorded
Head and Neck Squamous Cell Carcinoma
Lead sponsor
Merus B.V.
Study type
Interventional
Overall status
Recruiting · this can differ by location
Age range in the record
18 Years to Not specified
Sex eligibility field
All
Healthy volunteers accepted
No, according to the record
Phase
Phase3
Study record last updated
2 June 2026
Study team last verified status
2026-04

These fields are a starting point. Eligibility can include diagnosis, treatment history and other criteria shown only in the complete source record. A registry entry does not establish treatment effectiveness.

England study locations

A location is reproduced as named in the study record. A source map point can represent a town; it is not used here as a hospital entrance or to identify a care provider.

Location in the sourceLocal recruitment statusGeographic connection
Site 102

Cambridge · CB20QQ

RecruitingCare in Cambridge

England postcode

Site 132

London · EC1A 7BE

RecruitingCare in City of London

England postcode

Site 90

London · SE19RT

RecruitingCare in Southwark

England postcode

Site 69

London · SW3 6JJ

RecruitingCare in Kensington and Chelsea

England postcode

Site 173

Manchester · M20 4BX

RecruitingCare in Manchester

England postcode

Site 177

Newcastle upon Tyne · NE7 7DN

RecruitingCare in Newcastle upon Tyne

England postcode

Site 83

Northwood · HA62RN

RecruitingCare in Hillingdon

England postcode

Site 147

Southampton · SO16 6YD

RecruitingCare in Southampton

England postcode

Site 70

Sutton · SM2 5PT

RecruitingCare in Sutton

England postcode

Site 135

Taunton · TA1 5DA

RecruitingCare in Somerset

England postcode

Questions for the research team

  • Is this exact location currently enrolling participants, and do my circumstances meet the full criteria?
  • What visits, tests, possible risks and follow-up would participation involve?
  • Are travel costs or accessibility arrangements available?
  • How would participation affect my usual care, and what happens if I withdraw?

Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).

Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.

How we selected and connected these records

Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.